Predominant expression of the B-cell marker B220 and weaker expression of the T-cell marker CD3e confirmed their B-cell origin, similar to that of the original transferred lymphoma (Fig. S11, Supporting Information). The gene discussed is PTPRC; the disease is lymphoma.